Skip to main content

Global Adhesion Barrier Market Competition, Risk, Value and Importance Forecast to 2025

Global Adhesion Barrier Market is expected to register a CAGR of 7.32% during the forecast period of 2019 to 2025 and expected to reach USD 928.78 Million by 2025.
The Global Adhesion Barrier Market is expected to grow at a stable pace. The increasing surgical procedures for small bowel obstruction, infertility, & chronic pelvic pain, cost-effective prevention of adhesions, and increasing product development, among others, is expected boost the growth of the market. However, the risk of using adhesion barrier in patients with a history of hypersensitivity and the choice of using adhesion barriers among surgeons have been major factors hampering the growth of the market
Segmentation
The Global Adhesion Barrier Market has been segmented into product, formulation, severity, and application.
By product, the market has been segmented into synthetic adhesion barriers and natural adhesion barriers. The synthetic adhesion barriers are further segmented into hyaluronic acid, regenerated cellulose, polyethylene glycol, and among others. The accounted for major market share owing to various advantages over natural adhesion barriers and the cost-effectiveness of these products.
On the basis of formulation, the global adhesion barrier market is bifurcated into film, gel, and liquid. Film-based adhesion owing to better handling characteristics and positive results compared to other types of adhesion barriers.
On the basis of severity, the market is segmented into mild adhesion, severe adhesion. Based on application the market is segmented into gynecological surgeries, general/abdominal surgeries, orthopedic surgeries, cardiovascular surgeries, neurological surgeries, urological surgeries, reconstructive surgeries and other
Key Players
Some of the Key Players in the Global Adhesion Barrier Market are Johnson & Johnson, Anika Therapeutics, Atrium Medical Corporation (A Part of Getinge Group), Baxter International, Betatech Medical, C. R. Bard, FzioMed, Innocoll Holdings, Integra LifeSciences Holdings Corporation, MAST Biosurgery, Normedi Nordic, and Sanofi, among others.
Regional Analysis
On a regional basis, the market has been segmented into four major regions including the Americas, Europe, Asia-Pacific, and Middle East & Africa. Americas is anticipated to dominate the global adhesion barrier market owing to the presence of a large number of medical device companies, rising research and development, increasing laparoscopy procedures, and the presence of a large patient pool. Europe is expected to account for the second-largest share in the global adhesion barrier market owing to the increasing utilization of advanced adhesion barriers and the increasing development of products by existing manufacturers. Asia-Pacific is expected to be the fastest-growing regional market. This is attributed to a large patient pool in hugely populated countries like China, India, and Indonesia among others, increasing gynecological surgeries, rising government programs for the awareness of women related diseases.
Furthermore, various major players are keen on investing in the region owing to high untapped opportunities. The Middle East & Africa accounted for the least market share. However, the presence of untapped markets in the region and rise in awareness among patients about the advantages of adhesion barriers would provide growth opportunities in the coming years.
About Market Research Future: MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
+1 646 845 9312 | Email: sales@marketresearchfuture.com

Comments

Popular posts from this blog

Immunoassay Analyzers Market By Methods, Technologies, Clinical Review and Industry Outlook

  Immunoassay Analyzers Market  Research Report By Instruments (Immunofluorescence, Chemiluminescence, ELISA, Radioimmunoassay), Application (Infectious Diseases, Autoimmune Diseases, AIDS), End Users (Hospitals)- Global Forecast till 2023 Market Scenario Immunoassay analyzer is a device which measures the presence and concentration of proteins in analyte samples. These instruments are mostly used by pharmaceutical & biotechnological companies, laboratories, and research institutes. The global immunoassay analyzer market is driven by an increasing number of pharmaceutical and biotechnological companies, rising prevalence of different life-threatening diseases, and government’s initiatives for research & development activities. Furthermore, rapid development in diagnostic medical devices, increasing need for better drug treatment, and the increasing geriatric population had also fueled the market’s growth. On the other hand, high cost of instruments and poor reimburseme...

Laser Therapy Market Top Company Profiles, Latest Technology, Global Size, Industry Trends

  Laser Therapy Market  Research Report, By Type (Diode Lasers, Solid State Lasers, Gas Lasers, Dye Lasers, and others), By Application (Dermatology and Aesthetics, Surgery, Dental, Urology, Ophthalmology, and others) - Global Forecast from 2017 to 2023 Market Overview: Market Research Future (MRFR) anticipates strong CAGR of 9.2% in the global laser therapy market over the forecast period of 2017-2023. The expansion of the global laser therapy is the result of various market dynamics, out of which, the surging prevalence of diseases such as cataract and arthritis bears profound weightage. Laser therapy is the standard line of treatment in cases of cataract. Laser-based ophthalmology is highly preferred over other methods of treatment. YAG LASER, excimer LASER, femtosecond LASER, and others are the most commonly used lasers in ophthalmology. The widespread prevalence of cataract, as well as arthritis, promote the growth of the global laser therapy market. Expanding base of old...

Nonallergic Rhinitis Market Data, Technology Treatment and Diagnosis Management Overview

  Nonallergic Rhinitis Market  Share, Growth And Trends Analysis By Diagnosis (Physical Examination, Allergy Testing, And Imaging Test), By Treatment (Nasal Sprays, Nsaids), And By End User (Hospitals &, Clinics, Research Centers) - Global Forecast Till 2023 Market Highlights Nonallergic rhinitis, also known as vasomotor rhinitis is a medical condition that refers to a set of symptoms that resemble nasal allergies and hayfever (allergic rhinitis) occurring without a known cause. Some of the symptoms of non-allergic rhinitis include Postnasal drip, Runny nose, Sneezing, and Stuffy nose among others. Some patients with nonallergic rhinitis may even develop allergies and asthma eventually, hence treating the condition well in time becomes essential. Industry, Innovation & Related News November 08, 2018 – AstraZeneca Plc. (the UK), a multinational pharmaceutical and biopharmaceutical company announced the sale of its rights for asthma drug Alvesco (ciclesonide), nasal spra...